Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
anticoagulant/inflammation
Länken sparas på Urklipp
Sida 1 från 62 resultat
Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine
Isocoumarins with basic substituents as serine proteases inhibitors, anticoagulants and anti-inflammatory agents
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine
Locally-active anticoagulants and anti-inflammatory agents
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention is related to novel thrombin inhibitors as anti-thrombotic agents and locally-active anticoagulants and anti-inflammatory agents.
BACKGROUND OF THE INVENTION
Thrombotic complications constitute major life-threatening conditions for both the aging
Chromatographic purification of human proteins having anticoagulant and anti-inflammatory activity
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The present invention relates to the production and use of proteins in general, and more specifically, to the production of novel proteins exhibiting anticoagulant and anti-inflammatory activity, DNA sequences encoding these proteins, and the use of these proteins in warmblooded
Heparin cofactor II fragments with anti-inflammatory and anti-coagulant activity
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Phase application under 35 U.S.C. .sctn.371 of International Application No. PCT/GB2010/001780 filed Sep. 21, 2010 and claims the benefit of Great Britain Application No. 0916578.8 filed Sep. 22, 2009, the disclosures of which
System and method of extracorporeally treating blood to alleviate the symptoms of inflammatory diseases
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to an extracorporeal blood circulation system for treating inflammatory diseases. More particularly, the present invention is concerned with an extracorporeal blood circulation system for treating inflammatory
Anti-infective and anti-inflammatory releasing systems for medical devices
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
This invention relates to invasive medical devices for delayed/sustained release of pharmaceutical compositions from a polymer that is coated or incorporated into the devices. The purpose of the coating or delivery system on these devices is to reduce, control or even
Antibodies to IL-6 to inhibit or treat inflammation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The sequence listing in the file named "43272ol1805.txt" having a size of 341,671 bytes that was created Apr. 3, 2014 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
Sulfated oligosaccharide derivatives
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention described herein relates to compounds having activity as inhibitors of heparan sulfate-binding proteins, including the enzyme heparanase. In particular, the invention is directed to sulfated oligosaccharide derivatives, although the scope of the invention is not
Solution and method for adhering suspension components to a substrate
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
This disclosure relates generally to analyzing a suspension and, in particular, to a solution and method for adhering a component of a suspension to a substrate.
BACKGROUND
Current diagnostic methods and techniques rely on the interpretation of histological and cytological samples.
Solution and method for adhering suspension components to a substrate
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
This disclosure relates generally to analyzing a suspension and, in particular, to a solution and method for adhering a component of a suspension to a substrate.
BACKGROUND
Current diagnostic methods and techniques rely on the interpretation of histological and cytological samples.
Sulfated oligosaccharide derivatives
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention described herein relates to compounds having activity as inhibitors of heparan sulfate-binding proteins and as inhibitors of the enzyme heparanase. In particular, the invention is directed to sulfated oligosaccharide derivatives, although the scope of the invention is
Sulfated oligosaccharide derivatives
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
TECHNICAL FIELD
The invention described herein relates to compounds having activity as inhibitors of heparan sulfate-binding proteins and as inhibitors of the enzyme heparanase. In particular, the invention is directed to sulfated oligosaccharide derivatives, although the scope of the invention is
Isocoumarins with cationic substituents
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a novel class of heterocyclic compounds useful for selectively inhibiting trypsin-like enzymes, selectively inhibiting chymotrypsin-like enzymes, selectively inhibiting elastase or for generally inhibiting serine
Simukunin
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND
Certain medical conditions, such as strokes, cardiovascular blockages, deep vein thrombosis, and pulmonary embolism, are treated with the administration of an anticoagulant, to prevent the formation of blood clots and the extension of existing clots. A widely used anticoagulant is
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
